Animal model for pharmacokinetic approach to individualized heparin dosage regimen for i.v. infusion by constant rate to achieve and maintain a desired clotting time
- PMID: 546429
Animal model for pharmacokinetic approach to individualized heparin dosage regimen for i.v. infusion by constant rate to achieve and maintain a desired clotting time
Abstract
A pharmacokinetic approach was developed for the determination of an individualized heparin dosage regimen for an i.v. constant infusion rate. The rabbit was chosen as the animal model. From a test dose given i.v. the individual rate constant for loss of anticoagulant response was determined by measuring the whole blood activated clotting time. After selection of a desired clotting time to be maintained, the loading dose and infusion rate or heparin concentration at set infusion rate were calculated. In the three infusion studies used to illustrate this method, less than a 4% average deviation resulted between the actual clotting times and the desired clotting times.
Similar articles
-
Improved methods for estimating initial heparin infusion rates.Am J Hosp Pharm. 1979 Jun;36(6):782-4. Am J Hosp Pharm. 1979. PMID: 463894
-
Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.J Thorac Cardiovasc Surg. 1990 Mar;99(3):518-27. J Thorac Cardiovasc Surg. 1990. PMID: 2308370
-
Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.Clin Nephrol. 1983 Feb;19(2):82-6. Clin Nephrol. 1983. PMID: 6839556
-
Pharmacokinetics of heparin. II. Studies of time dependence in rats.J Pharmacol Exp Ther. 1979 Aug;210(2):243-6. J Pharmacol Exp Ther. 1979. PMID: 458631
-
Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.Am J Vet Res. 1985 Jul;46(7):1460-2. Am J Vet Res. 1985. PMID: 4026027